Accredited official statistics

MSSA bacteraemia: annual data

Annual counts and rates of meticillin susceptible Staphylococcus aureus (MSSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).

Documents

MSSA bacteraemia: financial year counts and rates by acute trust and sub-integrated care board location, up to financial year 2023 to 2024

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: financial year counts and rates by acute trust and sub-integrated care board location, up to financial year 2022 to 2023

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: financial year counts and rates by acute trust and sub-integrated care board location, up to financial year 2022 to 2023 (open source)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: financial year counts and rates by acute trust and CCG, up to financial year 2021 to 2022 (open source)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: financial year counts and rates by acute trust and CCG, up to financial year 2020 to 2021

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: financial year counts and rates by acute trust and CCG, up to financial year 2020 to 2021 (open source)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: financial year counts and rates by acute trust and CCG, up to financial year 2019 to 2020

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: financial year counts and rates by acute trust and CCG, up to financial year 2018 to 2019

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: financial year counts and rates by acute trust and CCG, up to financial year 2018 to 2019 (open source)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: quarterly counts by acute trust and CCG, and financial year counts and rates by acute trust and CCG, up to financial year 2017 to 2018

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: quarterly counts by acute trust and CCG, and financial year counts and rates by acute trust and CCG, up to financial year 2016 to 2017

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: quarterly counts by acute trust and CCG, and financial year counts and rates by acute trust and CCG, up to financial year 2015 to 2016

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: quarterly counts by acute trust and CCG, and financial year counts and rates by acute trust and CCG, up to financial year 2014 to 2015

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MSSA bacteraemia: quarterly counts by acute trust and CCG, and financial year counts and rates by acute trust and CCG, up to financial year 2013 to 2014

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The following data is included in the latest annual publication for MSSA bacteraemia.

From September 2023

Results by NHS organisation and sub-integrated care board location (SICBL)

  • financial year counts and rates of C. difficile infection and by prior trust exposure from April 2007 to March 2023

From September 2021

Results by NHS organisation

  • financial year counts and rates of MRSA bacteraemia and by onset status from April 2007 to March 2021

From July 2018

Results by NHS acute trust

  • quarterly counts of MSSA bacteraemia by NHS acute trust and by onset status from January 2011 to March 2018 - all reported cases (table 11a)
  • quarterly counts of MSSA bacteraemia by NHS acute trust from January 2011 to March 2018 - trust apportioned cases only (table 11b)
  • financial year counts and rates of MSSA bacteraemia by NHS acute trust from April 2011 to March 2018 - all reported cases (table 12a)
  • financial year counts and rates of MSSA bacteraemia by acute trust from April 2011 to March 2018 - trust apportioned cases only (table 12b)

Results by clinical commissioning group (CCG)

  • quarterly counts of MSSA bacteraemia by clinical commissioning group (CCG) from January 2011 to March 2018 (table 13)
  • financial year counts and rates of MSSA bacteraemia by clinical commissioning group (CCG) from April 2011 to March 2018 (table 14)

For commentary on this data, see MRSA, MSSA and Gram-negativei bacteraemia and C. difficile infection: annual epidemiological commentary.

From July 2014

Results by NHS acute trust

  • quarterly counts of MSSA bacteraemia by acute trust from January 2011 to March 2017 - all reported cases (table 11a)
  • quarterly counts of MSSA bacteraemia by acute trust from January 2011 to March 2017 - trust apportioned cases only (table 11b)
  • financial year counts and rates of MSSA bacteraemia by acute trust from April 2011 to March 2017 - all reported cases (table 12a)
  • financial year counts and rates of MSSA bacteraemia by acute trust from April 2011 to March 2017 - trust apportioned cases only (table 12b)

Results by CCG

  • quarterly counts of MSSA bacteraemia by clinical commissioning group (CCG) from January 2011 to March 2017 (table 13)
  • financial year counts and rates of MSSA bacteraemia by clinical commissioning group (CCG) from April 2011 to March 2017 (table 14)

For older MSSA tables, see the UK Government Web Archive.

Updates to this page

Published 10 July 2014
Last updated 26 September 2024 + show all updates
  1. Added annual data for the financial year April 2023 to March 2024.

  2. Added annual data for the financial year April 2022 to March 2023.

  3. Added annual data for the financial year April 2021 to March 2022.

  4. Added annual data for the financial year April 2020 to March 2021.

  5. Added annual data for the financial year April 2019 to March 2020.

  6. Added annual data for the financial year April 2018 to March 2019.

  7. Added annual data for the financial year April 2017 to March 2018.

  8. Added annual data for the financial year April 2016 to March 2017.

  9. Added annual data for the financial year April 2015 to March 2016.

  10. Annual data for the financial year April 2014 to March 2015 added.

  11. First published.

Sign up for emails or print this page